kabutan

Human Metabolome Technologies, Inc.(6090) Summary

6090
TSE Standard
Human Metabolome Technologies, Inc.
642
JPY
-2
(-0.31%)
Dec 12, 3:30 pm JST
4.12
USD
Dec 12, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
13.9
PBR
2.14
Yield
2.80%
Margin Trading Ratio
Stock Price
Dec 12, 2025
Opening Dec 12, 9:00 am
650 JPY 4.18 USD
Previous Close Dec 11
644 JPY 4.12 USD
High Dec 12, 10:11 am
654 JPY 4.20 USD
Low Dec 12, 11:17 am
631 JPY 4.05 USD
Volume
9,400
Trading Value
6.00M JPY 0.04M USD
VWAP
643.8 JPY 4.13 USD
Minimum Trading Value
64,200 JPY 412 USD
Market Cap
3.80B JPY 0.02B USD
Number of Trades
48
Liquidity & Number of Trades
As of Dec 12, 2025
Liquidity
Slightly Low
1-Year Average
36
1-Year High Jul 1, 2025
282
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 5, 2025 0 223,200
Nov 28, 2025 0 222,900
Nov 21, 2025 0 223,200
Nov 14, 2025 0 227,800
Nov 7, 2025 0 227,400
Company Profile
Human Metabolome Technologies, Inc. is a biotech venture company originating from Keio University. The company specializes in metabolite analysis services and biomarker detection.
Sector
Services
Human Metabolome Technologies develops businesses utilizing metabolome analysis and biotechnology. Through its comprehensive metabolite analysis technology using CE-MS method, the company engages in two main business areas: advanced research and development support, and healthcare solutions. In the former, the company provides metabolome analysis services to food, chemical, and pharmaceutical companies, as well as research institutions. In the latter, it supports the development of functional materials.